105 related articles for article (PubMed ID: 3039431)
21. Adriamycin in the treatment of resectible and irresectible primary hepatocellular carcinoma.
Oon CJ; Chua EJ; Foong WC; Tan LK; Yo SL; Chang CH; Ho ST; Seah CS
Ann Acad Med Singap; 1980 Apr; 9(2):256-9. PubMed ID: 6252816
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
[TBL] [Abstract][Full Text] [Related]
23. Primary liver cancer. An Eastern Cooperative Oncology Group Trial.
Falkson G; MacIntyre JM; Moertel CG; Johnson LA; Scherman RC
Cancer; 1984 Sep; 54(6):970-7. PubMed ID: 6088019
[TBL] [Abstract][Full Text] [Related]
24. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
Osuga K; Murakami T; Nakata S; Tomoda K; Nagano H; Monden M; Nakamura H
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2114-7. PubMed ID: 15628754
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
[TBL] [Abstract][Full Text] [Related]
26. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
[TBL] [Abstract][Full Text] [Related]
27. [Effects of intraarterial infusion chemotherapy on liver function in patients with hepatocellular carcinoma].
Abe K; Sugata F; Takizawa K; Yoshiba M; Takagi T; Higashi S; Kuniyasu Y
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1898-902. PubMed ID: 1652227
[TBL] [Abstract][Full Text] [Related]
28. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
[TBL] [Abstract][Full Text] [Related]
29. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
30. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
Qin S; Bai Y; Lim HY; Thongprasert S; Chao Y; Fan J; Yang TS; Bhudhisawasdi V; Kang WK; Zhou Y; Lee JH; Sun Y
J Clin Oncol; 2013 Oct; 31(28):3501-8. PubMed ID: 23980077
[TBL] [Abstract][Full Text] [Related]
31. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial.
Falkson G; Moertel CG; Lavin P; Pretorius FJ; Carbone PP
Cancer; 1978 Nov; 42(5):2149-56. PubMed ID: 214218
[TBL] [Abstract][Full Text] [Related]
33. [Non resectable colonic cancer. Results from a test of chemotherapy with simultaneous prescription of VM26, methyl-CCNU and 5 fluoro-uracile (author's transl)].
Pouillart P; Palangie T; Jouve M; Langlois A; Garcia-Giralt E; Regensberg C; Blic V; Huguenin P; Morin P; Gautier H; Baron A; Dat-Xuong
Nouv Presse Med; 1978 Jun; 7(25):2235-8. PubMed ID: 673790
[TBL] [Abstract][Full Text] [Related]
34. Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma.
Falkson G; MacIntyre JM; Schutt AJ; Coetzer B; Johnson LA; Simson IW; Douglass HO
J Clin Oncol; 1984 Jun; 2(6):581-4. PubMed ID: 6327926
[TBL] [Abstract][Full Text] [Related]
35. [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
Nakazaki H; Kuramoto S; Watanabe M; Maeda T; Hanawa S; Hasebe Y; Suzuki Y; Yanagita K; Yoshio T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1501-3. PubMed ID: 1326917
[TBL] [Abstract][Full Text] [Related]
36. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
[No Abstract] [Full Text] [Related]
37. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
Obi S; Yoshida H; Toune R; Unuma T; Kanda M; Sato S; Tateishi R; Teratani T; Shiina S; Omata M
Cancer; 2006 May; 106(9):1990-7. PubMed ID: 16565970
[TBL] [Abstract][Full Text] [Related]
38. Clinical studies in Asian patients with irresectible primary hepatocellular carcinoma treated by adriamycin and prednisolone alone or in combination with 5-fluorouracil, vincristine and prednisolone.
Singapore Med J; 1978 Dec; 19(4):192-204. PubMed ID: 220733
[No Abstract] [Full Text] [Related]
39. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC).
De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
